iCAD Investor Relations Material
Latest events
Status Update
iCAD
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from iCAD Inc
Access all reports
iCAD Inc. is a medical technology company focused on providing innovative solutions for cancer detection and therapy. The company develops advanced imaging and radiation therapy technologies, including artificial intelligence-based software for early cancer detection, particularly in mammography, and radiation therapy systems for treating cancerous tumors. iCAD’s products aim to improve diagnostic accuracy and treatment outcomes for patients while supporting healthcare providers with efficient and precise tools. The company is headquartered in Nashua, New Hampshire, and its shares are listed on the NASDAQ.
Key slides for iCAD Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ICAD
Country
🇺🇸 United States